Canada markets closed

Nemaura Medical Inc. (NMRD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
7.93-0.63 (-7.36%)
At close: 4:00PM EDT

8.10 +0.17 (2.14%)
After hours: 7:52PM EDT

Nemaura Medical Inc.

57 West 57th Street
Manhattan
New York, NY 10019
United States
646 416 8000
http://nemauramedical.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees17

Key Executives

NameTitlePayExercisedYear Born
Dr. Dewan Fazlul Hoque Chowdhury Ph.D.Chairman, CEO & Pres103.77kN/A1973
Mr. Justin MclarneyChief Fin. OfficerN/AN/AN/A
Mr. Bashir TimolChief Bus. Officer & DirectorN/AN/A1974
Mr. Jay L. WarnerHead of U.S. Commercial OperationsN/AN/AN/A
Mr. Thomas Bendix MortensenHead of E.U. Commercial Operations & MarketingN/AN/AN/A
Ms. Samantha SandersGlobal Head of Digital ProgramsN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. It has a license agreement with Healthimation, LLC, which licenses the company to make, have made, use, offer to sell, sell, and import intensive medical diabetes and weight management program for Type 2 diabetes, prediabetes, and general wellness; the Why WAIT app; and common law trademarks which incorporate the mark WHY WAIT or WHYWAIT and the use of licensed marks. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

Corporate Governance

Nemaura Medical Inc.’s ISS Governance QualityScore as of April 30, 2021 is 7. The pillar scores are Audit: 10; Board: 8; Shareholder Rights: 2; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.